A simple and non-invasive imaging
method can effectively replace the current practice in Breast cancer
treatment. This reduces the need for invasive tissue sampling. This
research work was carried out in London. The results suggest that the
method might lead to more optimal treatment of individual patients.
Jens
Sorensen who is one of the researchers from Uppsala University said,
"This new method might substitute invasive tissue sampling in future. We
have measured the growth factor HER2 (human epidermal growth factor
receptor type 2) and this is an important tool for deciding correct
treatment in breast cancer.
The only
drawback in this treatment is that it is highly expensive. But still it
saves lives of many women.The current diagnosis of elevated HER2
expression is based on examination of tissue samples obtained by surgery
or needle biopsies from the liver, bones and other organs.
Right
now research work is going on with women who suffers from metastatic
breast cancer. This therapy is done by means of targeted drug delivery.